Crystals of peptide deformylase from Plasmodium falciparum reveal critical characteristics of the active site for drug design
about
An unusual peptide deformylase features in the human mitochondrial N-terminal methionine excision pathwayHuman mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibioticsCrystal structure of type II peptide deformylase from Staphylococcus aureusStructural variation and inhibitor binding in polypeptide deformylase from four different bacterial speciesA new native EcHsp31 structure suggests a key role of structural flexibility for chaperone functionThe Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking InvestigationsLigand-induced changes in the structure and dynamics of Escherichia coli peptide deformylaseThe crystal structure of mitochondrial (Type 1A) peptide deformylase provides clear guidelines for the design of inhibitors specific for the bacterial forms.Parasite plastids: maintenance and functionsParasite plastids: approaching the endgame.Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation.Small molecule inhibition of apicomplexan FtsH1 disrupts plastid biogenesis in human pathogens.An improved crystal form of Plasmodium falciparum peptide deformylase
P2860
Q24297180-EBE4C58E-39E7-4DB1-A84B-3AF3FC87B4BBQ24307590-C98045B6-D5FF-479F-A99D-EB4EDF3CFBBCQ27639075-DB5B133F-F118-4217-9B49-4B3A8863E686Q27640341-716521A2-231E-49A7-AF30-7159AC402F61Q27642847-11F3AEDF-F387-4BF0-BCD1-8C7CCB81A0A0Q28066944-60DF14DA-FD3F-46E0-9FB7-CE50F0ED21B0Q33896611-4E50D00E-ACE1-4D14-B9E5-DAE48EC18A18Q34455068-C9642932-CBB5-40A0-9DD8-B9047A7B7FE9Q35213409-6E0BC4B4-7D91-4702-9DD4-8DD4A9BA8D3BQ36052586-16B526F2-6768-4617-8B0A-E119DEDE266EQ36458601-214D0BB3-4175-4DE6-9D8F-F3DEC083F362Q40085628-69230C7A-1729-4A8C-8A9B-1BA9B3FE1F0FQ42114442-4199BFA3-51D2-4435-A34D-F7C101B17646
P2860
Crystals of peptide deformylase from Plasmodium falciparum reveal critical characteristics of the active site for drug design
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Crystals of peptide deformylas ...... he active site for drug design
@ast
Crystals of peptide deformylas ...... he active site for drug design
@en
Crystals of peptide deformylas ...... he active site for drug design
@nl
type
label
Crystals of peptide deformylas ...... he active site for drug design
@ast
Crystals of peptide deformylas ...... he active site for drug design
@en
Crystals of peptide deformylas ...... he active site for drug design
@nl
prefLabel
Crystals of peptide deformylas ...... he active site for drug design
@ast
Crystals of peptide deformylas ...... he active site for drug design
@en
Crystals of peptide deformylas ...... he active site for drug design
@nl
P2093
P1433
P1476
Crystals of peptide deformylas ...... he active site for drug design
@en
P2093
Brad Ornstein
Irwin Hirsh
Kiet T Nguyen
Stewart Turley
Sumant Srivathsan
Wim G J Hol
P304
P356
10.1016/S0969-2126(02)00719-0
P577
2002-03-01T00:00:00Z